Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Industry News

First of Its Kind Technology Reduces Stroke by More Than 60 Percent in Patients Undergoing Common Heart Procedure

May 02, 2018

News Industry News

Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance

November 01, 2016

News Industry News

Mitralign Announces Enrollment of First U.S. Subject in Percutaneous Tricuspid Repair Study

December 02, 2015

News Industry News

SAPIEN 3 Valve Demonstrates Low Mortality, Excellent 30-Day Outcomes In High- And Intermediate-Risk Patients

March 15, 2015

News Industry News

Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System

September 23, 2014

News Industry News

REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System

September 15, 2014

News Industry News

Boston Scientific Receives CE Mark For The New 25 mm Lotus™ Valve System

July 14, 2014

News Industry News

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

June 04, 2014

News Industry News

Transcatheter Technologies receives Second tranche of Series B cash infusion

June 02, 2014

News Industry News

DIRECT FLOW MEDICAL, INC. ANNOUNCES IDE APPROVAL FOR U.S. PIVOTAL TRIAL

May 21, 2014

News Industry News

Boston Scientific Lotus™ Valve System Demonstrates Strong Performance And Safety Profile At Six Months

May 21, 2014

Advertisement

First of Its Kind Technology Reduces Stroke by More Than 60 Percent in Patients Undergoing Common Heart Procedure

Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance

Mitralign Announces Enrollment of First U.S. Subject in Percutaneous Tricuspid Repair Study

SAPIEN 3 Valve Demonstrates Low Mortality, Excellent 30-Day Outcomes In High- And Intermediate-Risk Patients

Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System

REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System

Boston Scientific Receives CE Mark For The New 25 mm Lotus™ Valve System

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

Transcatheter Technologies receives Second tranche of Series B cash infusion

DIRECT FLOW MEDICAL, INC. ANNOUNCES IDE APPROVAL FOR U.S. PIVOTAL TRIAL

Boston Scientific Lotus™ Valve System Demonstrates Strong Performance And Safety Profile At Six Months

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content